Neoadjuvant Therapy for Pancreatic Cancer: A Current Review

被引：21
|
作者：
Abbott, Daniel E. [1 ]
Baker, Marshall S. [2 ]
Talamonti, Mark S. [2 ]
机构：
[1] Northwestern Univ, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Univ Chicago, Dept Surg, NorthShore Univ Hlth Syst, Chicago, IL 60637 USA
来源：
JOURNAL OF SURGICAL ONCOLOGY | 2010年 / 101卷 / 04期
关键词：
pancreatic cancer; neoadjuvant; chemotherapy; radiation therapy; GEMCITABINE-BASED CHEMORADIATION; PHASE-II TRIAL; RESECTABLE ADENOCARCINOMA; RADIATION-THERAPY; PREOPERATIVE CHEMORADIOTHERAPY; SURGICAL RESECTION; CHEMOTHERAPY; PANCREATICODUODENECTOMY; SURVIVAL; LYMPHADENECTOMY;
D O I：
10.1002/jso.21469
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The optimal therapy for pancreatic cancer continues to evolve. Neoadjuvant chemoradiation is a key component of current treatment regimens, and evaluation of previous treatment options will help guide future trials. Here the authors present a review of the current literature with discussion of future directions. J. Surg. Oncol. 2010;101.-315-320. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码：315 / 320
页数：6
相关论文
共 50 条
  • [31] Role of Neoadjuvant Therapy in Management of Pancreatic Cancer
    Li, Jia
    Saif, Muhammad Wasif
    [J]. JOURNAL OF THE PANCREAS, 2014, 15 (04): : 354 - 357
  • [32] Total Neoadjuvant Therapy for Operable Pancreatic Cancer
    Kim, Rebecca Y.
    Christians, Kathleen K.
    Aldakkak, Mohammed
    Clarke, Callisia N.
    George, Ben
    Kamgar, Mandana
    Khan, Abdul H.
    Kulkarni, Naveen
    Hall, William A.
    Erickson, Beth A.
    Evans, Douglas B.
    Tsai, Susan
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (04) : 2246 - 2256
  • [33] Neoadjuvant Therapy of Pancreatic Cancer: The Emerging Paradigm?
    Lim, Kian-Huat
    Chung, Eugene
    Khan, Adeel
    Cao, Dengfeng
    Linehan, David
    Ben-Josef, Edgar
    Wang-Gillam, Andrea
    [J]. ONCOLOGIST, 2012, 17 (02): : 192 - 200
  • [34] Neoadjuvant Therapy is Essential for Resectable Pancreatic Cancer
    Xu, Jin-Zhi
    Wang, Wen-Quan
    Zhang, Shi-Rong
    Xu, Hua-Xiang
    Wu, Chun-Tao
    Qi, Zi-Hao
    Gao, He-Li
    Li, Shuo
    Ni, Quan-Xing
    Yu, Xian-Jun
    Liu, Liang
    [J]. CURRENT MEDICINAL CHEMISTRY, 2019, 26 (40) : 7196 - 7211
  • [35] Advances and challenges of neoadjuvant therapy in pancreatic cancer
    Yu, Yang
    Zheng, Peng
    Chen, Yajing
    Wang, Bofang
    Paul, Maswikiti Ewetse
    Tao, Pengxian
    Wang, Dengfeng
    Li, Haiyuan
    Gu, Baohong
    Gao, Lei
    Wang, Dan
    Chen, Hao
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (06) : 425 - 434
  • [36] Neoadjuvant Therapy in Pancreatic Cancer: An Emerging Strategy
    Bittoni, Alessandro
    Santoni, Matteo
    Lanese, Andrea
    Pellei, Chiara
    Andrikou, Kalliopi
    Stefano, Cascinu
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [37] Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits
    Heinrich, Stefan
    Lang, Hauke
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (08)
  • [38] Neoadjuvant Therapy for Patients with advanced Pancreatic Cancer
    Manekeller, Steffen
    [J]. ZENTRALBLATT FUR CHIRURGIE, 2021, 146 (02): : 153 - 153
  • [39] Evidence for Neoadjuvant Therapy in Resectable Pancreatic Cancer
    Niessen, Anna
    Buechler, Markus W.
    Hackert, Thilo
    [J]. ZENTRALBLATT FUR CHIRURGIE, 2022, 147 (02): : 168 - 172
  • [40] Status of Neoadjuvant Therapy for Resectable Pancreatic Cancer
    Hoffman, John P.
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (02) : 411 - +
12345